Family Medicine · Marquette, MI
NPI
1316946411
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
6044 US 41 S, Suite 3
Marquette, MI, 49855
Phone (906) 249-3600
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$45K
542 prescriptions
Company payments, 2025
$118
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Matthew S Doughty prescribed most often to Medicare patients was Np Thyroid (Thyroid,pork), with 120 prescriptions and refills. In total Matthew S Doughty wrote 542 Medicare prescriptions that cost $45K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-04-23.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Np Thyroid Thyroid,pork | 120 | 326 | 32 | $7,023 |
| Progesterone Progesterone, Micronized | 55 | 159 | 21 | $3,935 |
| Lisinopril Generic | 28 | 82 | Under 11 | $197 |
| Losartan Potassium Generic | 20 | 60 | Under 11 | $285 |
| Hydrocortisone Generic | 17 | 31 | Under 11 | $523 |
| Eliquis Apixaban | 15 | 23 | Under 11 | $13K |
| Liothyronine Sodium Generic | 15 | 33 | Under 11 | $753 |
| Thyroid Thyroid,pork | 13 | 35 | Under 11 | $1,117 |
| Valacyclovir Valacyclovir Hcl | 12 | 12 | Under 11 | $233 |
| Furosemide Generic | 12 | 14 | Under 11 | $159 |
| Levothyroxine Sodium Generic | 11 | 29 | Under 11 | $107 |
| Atorvastatin Calcium Generic | 11 | 33 | Under 11 | $186 |
Brand drugs: 47 claims; generic drugs: 356 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew S Doughty $118 ($118 in general payments such as food, travel and fees) from 1 company. The largest payer was Shockwave Medical, Inc with $118.
| Company | Payments | Amount |
|---|---|---|
| Shockwave Medical, Inc JNJ | 1 | $118 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.